AI assistant
Sending…
Rezolute, Inc. — Director's Dealing 2022
May 19, 2022
32362_dirs_2022-05-19_dbdd3620-173b-4865-b0f6-0ae88c5e8c3a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Rezolute, Inc. (RZLT)
CIK: 0001509261
Period of Report: 2022-05-17
Reporting Person: ROBERTS BRIAN KENNETH (Sr VP, Clinic Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-17 | Common Stock | P | 1000 | $3.4065 | Acquired | 22052 | Direct |
| 2022-05-18 | Common Stock | P | 200 | $2.8599 | Acquired | 22252 | Direct |
| 2022-05-19 | Common Stock | P | 300 | $2.9459 | Acquired | 22552 | Direct |
More from Rezolute, Inc.
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 24
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 12
Interim / Quarterly Report
2026
Feb 12
Major Shareholding Notification
2026
Jan 30
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 7
Major Shareholding Notification
2025
Dec 19